Skip to main content
Veterinary Medicines

ICTHIOVAC VR/PD, EMULSION FOR INJECTION FOR SEA BASS

Authorised
  • Photobacterium damselae, subsp. Piscicida, strain DI21, Inactivated
  • Vibrio anguillarum, serotype O1, Inactivated
  • Vibrio anguillarum, serotype O2B, Inactivated
  • Vibrio anguillarum, serotype O2A, Inactivated

Identifikacija zdravila

Ime zdravila:
ICTHIOVAC VR/PD, EMULSION FOR INJECTION FOR SEA BASS
ICTHIOVAC VR/PD, ενέσιμο γαλάκτωμα για λαβράκια
Učinkovina:
Pot uporabe:
  • Intraperitonealna uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    60.00
    Relative Percentage Survival
    /
    1.00
    Dose
  • Na voljo samo v English
    75.00
    Relative Percentage Survival
    /
    1.00
    Dose
  • Na voljo samo v English
    75.00
    Relative Percentage Survival
    /
    1.00
    Dose
  • Na voljo samo v English
    75.00
    Relative Percentage Survival
    /
    1.00
    Dose
Farmacevtska oblika:
  • Emulzija za injiciranje
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Seabass
      • Fish meat
        0
        degree day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI10X
Status dovoljenja:
  • Valid
Authorised in:
Ta podatek za to zdravilo ni na voljo.
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Laboratorios Hipra S.A.
Pristojni organ:
  • National Organization For Medicines
Številka dovoljenja :
  • 45403/16/16-08-2017/K-0223001
Datum spremembe statusa dovoljenja:
Številka postopka:
  • FR/V/0314/001
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."